We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS

Delisted

DALS was delisted on the 28th of July, 2023.

Back to rankings

43 hedge funds and large institutions have $151M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $140M → $151M (+$11.3M)

4% less funds holding

Funds holding: 45 → 43 (-2)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
+$3.66M
2
CSS
Cubist Systematic Strategies
Connecticut
+$2.96M
3
CF
Cantor Fitzgerald
New York
+$1.11M
4
WAM
Wolverine Asset Management
Illinois
+$1.05M
5
HCM
Highbridge Capital Management
New York
+$884K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$4.84M
2
WRBC
W.R. Berkley Corp
Connecticut
-$1.52M
3
CL
CSS LLC
Illinois
-$1.45M
4
Millennium Management
Millennium Management
New York
-$739K
5
MF
Magnetar Financial
Illinois
-$553K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$15.6M – – –
BlackRock
2
BlackRock
New York
$14.6M -$5.15K -530 -0%
RCM
3
RA Capital Management
Massachusetts
$14.6M – – –
SCM
4
Saba Capital Management
New York
$12.2M – – –
MF
5
Magnetar Financial
Illinois
$9.11M -$553K -56,889 -6%
Marshall Wace
6
Marshall Wace
United Kingdom
$8.73M – – –
Millennium Management
7
Millennium Management
New York
$7.8M -$739K -76,028 -9%
SC
8
Sculptor Capital
New York
$7.47M – – –
MCM
9
Moore Capital Management
New York
$7.27M – – –
Citadel Advisors
10
Citadel Advisors
Florida
$6.99M +$914 +94 +0%
MP
11
Mangrove Partners
Connecticut
$4.38M +$3.66M +376,644 +513%
CSS
12
Cubist Systematic Strategies
Connecticut
$4.33M +$2.96M +304,492 +216%
RIA
13
RP Investment Advisors
Ontario, Canada
$4.04M – – –
LA
14
Linden Advisors
New York
$3.7M – – –
CF
15
Cantor Fitzgerald
New York
$2.71M +$1.11M +113,753 +69%
AA
16
AQR Arbitrage
Connecticut
$2.49M – – –
Victory Capital Management
17
Victory Capital Management
Texas
$2.2M -$83.4K -8,580 -4%
GCM
18
Ghisallo Capital Management
Massachusetts
$2.19M – – –
SCM
19
Shaolin Capital Management
Florida
$2.19M – – –
NIP
20
Nicholas Investment Partners
California
$1.94M – – –
RCM
21
Radcliffe Capital Management
Pennsylvania
$1.61M – – –
WCMNY
22
Westchester Capital Management (New York)
New York
$1.61M – – –
Verition Fund Management
23
Verition Fund Management
Connecticut
$1.25M – – –
AIMCA
24
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.24M – – –
Toronto Dominion Bank
25
Toronto Dominion Bank
Ontario, Canada
$1.07M – – –
1
2

DALS Hedge Fund Activity: Q3 2022 in Review

43 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q3 2022, worth a combined $151M — up 8.1% from $140M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of DALS and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 5 added.

The largest buyer was Mangrove Partners, adding an estimated $3.66M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $4.84M sold.

  • 43 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q3 2022, down from 45 in Q2 2022.
  • Funds reported $151M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q3 2022, up 8.1% quarter-over-quarter.
  • 4 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q3 2022 and 5 closed out, a net change of -1 holder.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q3 2022 was Mangrove Partners, an estimated $3.66M added.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q3 2022 was Alyeska Investment Group, an estimated $4.84M sold.

Based on aggregated 13F filings for Q3 2022.